Deep Genomics

AI-driven genetic medicines platform company that collaborates across disciplines to solve molecular design and target biology problems in drug discovery.

About Deep Genomics

AI-driven genetic medicines platform company that collaborates across disciplines to solve molecular design and target biology problems in drug discovery.

Industries served

Products

  • BigRNA

    Drug Discovery & Biotech

    View product

    A proprietary, powerful BioFM trained on over a trillion signals derived from high-throughput sequencing datasets; predicts effects of genetic variants, fine-tunes for on/off-ta...

  • BioFM Platform

    Drug Discovery & Biotech

    View product

    A single engine with lab-in-the-loop workflows, AI model development and refinement, fit-for-purpose training datasets, AI output dataset assets, screening technologies, informa...

  • REPRESS

    Drug Discovery & Biotech

    View product

    A deep learning foundation model that predicts cell-type-specific miRNA binding and mRNA degradation directly from RNA sequence; identifies repressive non-canonical miRNA target...

  • DeepADAR

    Drug Discovery & Biotech

    View product

    A model that designs guide RNAs (gRNAs) to induce ADAR-mediated editing across various trinucleotide contexts; trained to predict endogenous ADAR editing based on local sequence...

Security and compliance

As reported by Deep Genomics. Ask for audit reports before you buy.

  • Administrative safeguards
  • Technical safeguards
  • Physical safeguards
  • Need-to-know access restriction
  • Record retention processes

Is this your company?

Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.

Claim Deep Genomics